Profile
| Metric | Value |
|---|---|
| Full Name | Syros Pharmaceuticals, Inc. |
| Ticker | NASDAQ: SYRS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | syros.com |
| Employees | 68 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $0.00 | |
| Price, 1D Change | +50.00% | |
| $8,050 | ||
| - | ||
| - | ||
| 2.76 | ||
| $10M | ||
| Revenue, 1Y Change | -33.23% | |
| -$5.81 | ||
| EPS, 1Y Change | +22.46% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$5.81 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $9.94M | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $0.00 | |
| Price Target | - | $5.50 |
| Price Tgt. Change | - | +1,833,233.33% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.73 | -$5.81 | -22.83% | |
| - | N/A | - | |
| -$2.61 | N/A | +55.12% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $11.52M | $9.94M | -13.75% | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $0.00 | |
| $0.01 | ||
| SMA 200 vs Price | +3,566.67% | |
| $0.00 | ||
| SMA 50 vs Price | +66.67% | |
| 2.76 | ||
| $0.00 | ||
| 50.00 | ||
| 2,173.71% | ||
| 5,959.44% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $9.94M | ||
| -$5.81 | ||
| $7.68M | ||
| 77.33% | ||
| -$126.50M | ||
| -1,273.14% | ||
| -$164.57M | ||
| -1,656.34% | ||
| -$157.20M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 3.73 | ||
| 3.95 | ||
| 3.95 | ||
| - | ||
| - | ||
| -8.31 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 0.02 | ||
| 0.00 | ||
| -0.02 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $16.66M | ||
| $139.53M | ||
| $168.17M | ||
| $144.98M | ||
| $151.51M | ||
| $36.68M | ||
| $62.08M | ||
| $8.99M | ||
| $11.54M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $136.44M | ||
| $136.44M | ||
| $2.25M | ||
| $28.28M | ||
| $2.25M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$109.71M | ||
| $37.34M | ||
| $43.46M | ||
| $272.00K | ||
| -$109.98M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| TD Cowen | → | |
| JMP Securities | → | |
| HC Wainwright & Co. | → | |
| Brookline Capital | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler | → | |
| JMP Securities | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with SYRS
FAQ
What is the ticker symbol for Syros Pharmaceuticals, Inc.?
The ticker symbol for Syros Pharmaceuticals, Inc. is NASDAQ:SYRS
Does Syros Pharmaceuticals, Inc. pay dividends?
No, Syros Pharmaceuticals, Inc. does not pay dividends
What sector is Syros Pharmaceuticals, Inc. in?
Syros Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Syros Pharmaceuticals, Inc. in?
Syros Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Syros Pharmaceuticals, Inc. based in?
Syros Pharmaceuticals, Inc. is headquartered in United States
When did Syros Pharmaceuticals, Inc. go public?
Syros Pharmaceuticals, Inc. initial public offering (IPO) was on June 30, 2016
Is Syros Pharmaceuticals, Inc. in the S&P 500?
No, Syros Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Syros Pharmaceuticals, Inc. in the NASDAQ 100?
No, Syros Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Syros Pharmaceuticals, Inc. in the Dow Jones?
No, Syros Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Syros Pharmaceuticals, Inc. last earnings report?
Syros Pharmaceuticals, Inc.'s most recent earnings report was on March 31, 2025
When does Syros Pharmaceuticals, Inc. report earnings?
The date for Syros Pharmaceuticals, Inc.'s next earnings report has not been announced yet
Data Sources & References
- SYRS Official Website www.syros.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1556263/000095017024119236/0000950170-24-119236-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1556263/000095017024036808/0000950170-24-036808-index.htm
- SYRS Profile on Yahoo Finance finance.yahoo.com/quote/SYRS
- SYRS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/syrs